Editas Medicine (EDIT) Misses Q3 EPS by 4c
Editas Medicine (NASDAQ: EDIT) reported Q3 EPS of ($0.64), $0.04 worse than the analyst estimate of ($0.60).
For earnings history and earnings-related data on Editas Medicine (EDIT) click here.
Editas Medicine (NASDAQ: EDIT) reported Q3 EPS of ($0.64), $0.04 worse than the analyst estimate of ($0.60).
For earnings history and earnings-related data on Editas Medicine (EDIT) click here.